We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$217M
AUM Growth
-$7.82M
Cap. Flow
+$2.35M
Cap. Flow %
1.08%
Top 10 Hldgs %
37.08%
Holding
944
New
14
Increased
196
Reduced
207
Closed
16

Top Buys

Rank Stock Value
1
DOV icon
Dover
DOV
+$3.14M
2
ENPH icon
Enphase Energy
ENPH
+$1.55M
3
GTLS
Chart Industries
GTLS
+$1.36M
4
ON icon
ON Semiconductor
ON
+$1.32M
5
NEE icon
NextEra Energy
NEE
+$1.02M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.71M
2
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
+$821K
3
CRSP icon
CRISPR Therapeutics
CRSP
+$818K
4
PNC icon
PNC Financial Services
PNC
+$788K
5
AGO icon
Assured Guaranty
AGO
+$698K

Sector Composition

Rank Sector Weight
1 Technology 41.16%
2 Healthcare 11.03%
3 Consumer Staples 7.01%
4 Financials 6.41%
5 Industrials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAD icon
551
Lithia Motors
LAD
$7.78B
$7.97K ﹤0.01%
27
-1
-4% -$305
PFGC icon
552
Performance Food Group
PFGC
$17.5B
$7.95K ﹤0.01%
135
+7
+5% +$423
GLOB icon
553
Globant
GLOB
$1.35B
$7.91K ﹤0.01%
40
– –
TTWO icon
554
Take-Two Interactive
TTWO
$43B
$7.86K ﹤0.01%
56
+15
+37% +$2.16K
IYG icon
555
iShares US Financial Services ETF
IYG
$2.13B
$7.78K ﹤0.01%
150
– –
CVCO icon
556
Cavco Industries
CVCO
$4.39B
$7.7K ﹤0.01%
29
+1
+4% +$280
IFLN
557
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$305M
$7.69K ﹤0.01%
450
– –
SNOW icon
558
Snowflake
SNOW
$92.9B
$7.64K ﹤0.01%
50
– –
EDIV icon
559
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$7.59K ﹤0.01%
255
– –
ATKR icon
560
Atkore
ATKR
$2.59B
$7.46K ﹤0.01%
50
– –
AON icon
561
Aon
AON
$77.3B
$7.46K ﹤0.01%
23
– –
PCTY icon
562
Paylocity
PCTY
$6.71B
$7.45K ﹤0.01%
41
-1
-2% -$201
PIPR icon
563
Piper Sandler
PIPR
$5.14B
$7.41K ﹤0.01%
204
-4
-2% -$145
NBIX icon
564
Neurocrine Biosciences
NBIX
$17.7B
$7.31K ﹤0.01%
65
-1
-2% -$105
ASX icon
565
ASE Group
ASX
$80.8B
$7.24K ﹤0.01%
963
– –
ENTG icon
566
Entegris
ENTG
$19.7B
$7.23K ﹤0.01%
77
– –
MRVL icon
567
Marvell Technology
MRVL
$174B
$7.2K ﹤0.01%
133
– –
SCHR
568
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$7.19K ﹤0.01%
300
– –
BTU icon
569
Peabody Energy
BTU
$2.78B
$7.12K ﹤0.01%
274
-7
-2% -$157
TAK icon
570
Takeda Pharmaceutical
TAK
$55.1B
$7.12K ﹤0.01%
460
– –
LII icon
571
Lennox International
LII
$18.8B
$7.11K ﹤0.01%
19
– –
DVA icon
572
DaVita
DVA
$15.1B
$7.09K ﹤0.01%
75
– –
TECK icon
573
Teck Resources
TECK
$29.5B
$7.07K ﹤0.01%
164
+29
+21% +$1.2K
PSK icon
574
State Street SPDR ICE Preferred Securities ETF
PSK
$693M
$6.98K ﹤0.01%
215
– –
BRKR icon
575
Bruker
BRKR
$9.2B
$6.98K ﹤0.01%
112
– –
21 22
23
24 25

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Front Row Advisors held 944 positions worth $217M, down 3.5% from $225M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.2%. Front Row Advisors opened 14 new positions and exited 16, leaving the 944-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q3 2023 buy was Enphase Energy: 10,850 shares worth $1.3M.
  • Front Row Advisors added most to Dover in Q3 2023, an estimated $3.14M increase.
  • Front Row Advisors's biggest Q3 2023 reduction was Idexx Laboratories, cutting an estimated $1.71M.
  • Front Row Advisors fully exited Fortune Brands Innovations in Q3 2023, selling an estimated $83K.
  • Front Row Advisors's ten largest holdings make up 37% of its $217M portfolio in Q3 2023.
  • Front Row Advisors opened 14 new positions and closed 16 in Q3 2023.
  • Front Row Advisors's portfolio value fell 3.5% quarter-over-quarter to $217M.

Based on Front Row Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.